Concepedia
Statistics
Publications
80
Citations
4.3K
H-Index
38
Active since
1995
Affiliations
Weifang Medical University(Current)
Takeda (United States)
Chinese Academy of Sciences
Institute of Zoology
Takeda (Japan)
Lihong Shi is an author at Weifang Medical University specializing in medicine, pharmacology, and molecular oncology.
Publications per year
1995–2024
Discovery of Alogliptin: A Potent, Selective, Bioavailable, and Efficacious Inhibitor of Dipeptidyl Peptidase IV
Jun Feng, Zhiyuan Zhang, Michael B. Wallace et al. · Journal of Medicinal Chemistry · 2007 · 404 citations · Full text
Medicine, Medicinal Chemistry, Pharmacology +6
Structural and Kinetic Analysis of the Substrate Specificity of Human Fibroblast Activation Protein α
Kathleen Aertgeerts, Irena Levin, Lihong Shi et al. · Journal of Biological Chemistry · 2005 · 281 citations · Full text
Life Sciences, Biochemistry, Molecular Biology +16
Rapid Identification of Highly Active and Selective Substrates for Stromelysin and Matrilysin Using Bacteriophage Peptide Display Libraries
Matthew M. Smith, Lihong Shi, Marc Navre · Journal of Biological Chemistry · 1995 · 147 citations · Full text
Life Sciences, Biochemistry, Molecular Biology +17
Design and Synthesis of Pyrimidinone and Pyrimidinedione Inhibitors of Dipeptidyl Peptidase IV
Zhiyuan Zhang, Michael B. Wallace, Jun Feng et al. · Journal of Medicinal Chemistry · 2010 · 124 citations · Full text
Pharmacy, Medicinal Chemistry, Pharmacology +16
Discovery of TAK-733, a potent and selective MEK allosteric site inhibitor for the treatment of cancer
Qing Dong, Douglas R. Dougan, Xianchang Gong et al. · Bioorganic & Medicinal Chemistry Letters · 2011 · 122 citations · Full text
Medicine, Oncology, Pharmacology +10
1–5 of 80